Skip to main content
SpringerLink
Log in

Prognostic usefulness of serum lactic dehydrogenase and its fifth isoenzyme levels in carcinoma of the prostate

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Antiandrogenic treatment with castration, intravenous diethylstilbestrol diphosphate and oral estradiol benzoate was given to 51 patients with prostatic carcinoma. The interrelationship between the clinical response to this treatment and the changes of serum lactic dehydrogenase (SLDH) and SLDH isoenzyme V fraction (SLDH-V) level was studied.

Pretreatment SLDH level is significant in regard to the 5-year survival rate. Response of SLDH and SLDH-V levels to antiandrogenic treatment has no significant influence on the 5-year survival rates. As regards the index of the 5-year survival rate in patients with prostatic carcinoma, SLDH-V was almost as specific as SLDH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Denis, L. J., Prout, G. R. Jr.: Lactic dehydrogenase in prostatic cancer.Invest. Urol. 1, 101 (1963).

    Google Scholar 

  2. Englhardt-Gölkel, A., Löbel, R., Seitz, W., Woller, I.: Über das Verhalten und die Herkunft glykolytischer Serumenzyme beim Menschen und ihre diagnostische Bedeutung.Klin. Wschr. 36, 462 (1958).

    Google Scholar 

  3. Hill, B. R., Levi, C.: Multiple oral carcinomas.Cancer 14, 512 (1954).

    Google Scholar 

  4. Iatron Co. Ltd.: Technical Bulletin ACP-S. Sanko-Junyaku, Tokyo 1970.

    Google Scholar 

  5. Ishibe, T.: Serum lactic dehydrogenase isoenzyme V fraction in prostatic carcinoma.Urologia (Treviso), in the press.

  6. Murphy, G. P., Reynoso, G., Kenny, G. M., Gaeta, J. F.: Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.Cancer 23, 1309 (1969).

    Google Scholar 

  7. Prout, G. R. Jr., Macalalag, E. V., Jr., Denis, L. J.: Alterations in serum lactic dehydrogenase and its isoenzymes in patients with prostatic carcinoma after hormonal therapy.Surg. Forum 15, 486 (1964).

    Google Scholar 

  8. Warburg, O., Posener, K., Negelein, E.: Über den Stoffwechsel der Carcinomzelle.Biochem. Z. 152, 309 (1924).

    Google Scholar 

  9. White, L. P.: Neoplastic disease. Effect of protein feeding on serum enzyme levels in patients with metastatic carcinoma.Clin. Res. Proc. 5, 84 (1957).

    Google Scholar 

  10. Wieme, P. J.: Agar Gel Electrophoresis. Elsevier Press Inc., Amsterdam 1965.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Hiroshima University School of Medicine, 734, Hiroshima, Japan

    T. Ishibe

Authors
  1. T. Ishibe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishibe, T. Prognostic usefulness of serum lactic dehydrogenase and its fifth isoenzyme levels in carcinoma of the prostate. International Urology and Nephrology 8, 221–225 (1976). https://doi.org/10.1007/BF02082243

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02082243

Keywords

Search

Navigation